Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial.
Juan F IglesiasOlivier MullerSylvain LosdatMarco RoffiDavid J KurzDaniel WeilenmannChristoph KaiserDik HegStephan WindeckerThomas PilgrimPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
In a post hoc subgroup analysis from the BIOSTEMI randomized trial, ultrathin-strut BP-SES were superior to thin-strut DP-EES with respect to TLF at 2 years among STEMI patients undergoing both complex and noncomplex pPCI.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- st elevation myocardial infarction
- acute coronary syndrome
- patients undergoing
- acute myocardial infarction
- coronary artery disease
- antiplatelet therapy
- coronary artery bypass grafting
- drug delivery
- atrial fibrillation
- heart failure
- randomized controlled trial
- phase iii
- open label
- study protocol